D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 20,699 277 World Ranking 12454 National Ranking 388
Biology and Biochemistry D-index 70 Citations 17,851 237 World Ranking 4420 National Ranking 296

Overview

What is he best known for?

The fields of study Yasuo Akanuma is best known for:

  • Gene
  • Enzyme
  • Signal transduction

Endocrinology is closely attributed to Body mass index in his work. Body mass index and Endocrinology are frequently intertwined in his study. He connects Insulin resistance with Type 2 diabetes in his study. In his research, he performs multidisciplinary study on Type 2 diabetes and Diabetes mellitus. He undertakes multidisciplinary investigations into Diabetes mellitus and Glucose tolerance test in his work. Yasuo Akanuma connects Glucose tolerance test with Insulin resistance in his research. His Internal medicine study frequently draws connections between related disciplines such as Insulin oscillation. His Insulin oscillation study typically links adjacent topics like Internal medicine. As part of his studies on Insulin, he often connects relevant subjects like Insulin receptor substrate.

His most cited work include:

  • The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity (4457 citations)
  • Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase (375 citations)
  • Risk factors for worsening to diabetes in subjects with impaired glucose tolerance (277 citations)

What are the main themes of his work throughout his whole career to date

A majority of his Cholesterol research is a blend of other scientific areas, such as Lipoprotein and Triglyceride. By researching both Lipoprotein and Cholesterol, Yasuo Akanuma produces research that crosses academic boundaries. His research is interdisciplinary, bridging the disciplines of Endocrinology and Triglyceride. Yasuo Akanuma regularly ties together related areas like Plasma glucose in his Endocrinology studies. Much of his study explores Internal medicine relationship to Plasma glucose. His research on Insulin often connects related topics like Glucose transporter. His Glucose transporter study frequently draws connections between related disciplines such as Insulin. He incorporates Biochemistry and Cell biology in his research. Yasuo Akanuma incorporates Cell biology and Biochemistry in his research.

Yasuo Akanuma most often published in these fields:

  • Endocrinology (85.19%)
  • Internal medicine (74.07%)
  • Insulin (49.38%)

What were the highlights of his more recent work (between 2001-2017)?

  • Internal medicine (71.43%)
  • Endocrinology (71.43%)
  • Optics (71.43%)

In recent works Yasuo Akanuma was focusing on the following fields of study:

Hazard ratio overlaps with fields such as Confidence interval and Proportional hazards model in his research. He performs integrative Confidence interval and Hazard ratio research in his work. As part of his studies on Proportional hazards model, Yasuo Akanuma often connects relevant subjects like Internal medicine. Yasuo Akanuma combines Internal medicine and Pediatrics in his studies. He integrates Pediatrics with Endocrinology in his study. Endocrinology is often connected to Hypoglycemia in his work. He combines Hypoglycemia and Type 2 diabetes in his research. Yasuo Akanuma integrates many fields in his works, including Type 2 diabetes and Body mass index. He integrates Body mass index and Diabetes mellitus in his research.

Between 2001 and 2017, his most popular works were:

  • Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS) (83 citations)
  • Low transition rate from normo- and low microalbuminuria to proteinuria in Japanese type 2 diabetic individuals: the Japan Diabetes Complications Study (JDCS) (58 citations)
  • HLA-DRw3 in Juvenile Onset Diabetes Mellitus in Chinese (26 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

Akira Okuno;Hiroyuki Tamemoto;Kazuyuki Tobe;Kohjiro Ueki.
Journal of Clinical Investigation (1998)

1413 Citations

Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the japanese population

Kazuo Hara;Philippe Boutin;Yasumichi Mori;Kazuyuki Tobe.
Diabetes (2002)

989 Citations

The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance

Toshimasa Yamauchi;Junji Kamon;Hironori Waki;Koji Murakami.
Journal of Biological Chemistry (2001)

764 Citations

Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.

Naoto Kubota;Kazuyuki Tobe;Yasuo Terauchi;Kazuhiro Eto.
Diabetes (2000)

629 Citations

Role of NADH Shuttle System in Glucose-Induced Activation of Mitochondrial Metabolism and Insulin Secretion

Kazuhiro Eto;Yoshiharu Tsubamoto;Yasuo Terauchi;Takuya Sugiyama.
Science (1999)

529 Citations

Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase

Y. Terauchi;Y. Tsuji;S. Satoh;H. Minoura.
Nature Genetics (1999)

521 Citations

A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.

K Murakami;K Tobe;T Ide;T Mochizuki.
Diabetes (1998)

511 Citations

Potential Role of Protein Kinase B in Insulin-induced Glucose Transport, Glycogen Synthesis, and Protein Synthesis

Kohjiro Ueki;Ritsuko Yamamoto-Honda;Yasushi Kaburagi;Toshimasa Yamauchi.
Journal of Biological Chemistry (1998)

459 Citations

Risk factors for worsening to diabetes in subjects with impaired glucose tolerance

T. Kadowaki;Y. Miyake;R. Hagura;Y. Akanuma.
Diabetologia (1984)

426 Citations

Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

Nigishi Hotta;Yasuo Akanuma;Ryuzo Kawamori;Kempei Matsuoka.
Diabetes Care (2006)

407 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Yasuo Akanuma

Takashi Kadowaki

Takashi Kadowaki

University of Tokyo

Publications: 220

Yasuo Terauchi

Yasuo Terauchi

Yokohama City University

Publications: 107

C. Ronald Kahn

C. Ronald Kahn

Harvard University

Publications: 85

Morris F. White

Morris F. White

Boston Children's Hospital

Publications: 79

Naoto Kubota

Naoto Kubota

University of Tokyo

Publications: 61

Kazuyuki Tobe

Kazuyuki Tobe

University of Toyama

Publications: 59

Nobuhiro Yamada

Nobuhiro Yamada

University of Tsukuba

Publications: 53

Philippe Froguel

Philippe Froguel

Imperial College London

Publications: 52

Hirohito Sone

Hirohito Sone

Niigata University

Publications: 51

Toshimasa Yamauchi

Toshimasa Yamauchi

University of Tokyo

Publications: 51

Yoshio Yazaki

Yoshio Yazaki

University of Tokyo

Publications: 48

Yoshitomo Oka

Yoshitomo Oka

Tohoku University

Publications: 46

Ryozo Nagai

Ryozo Nagai

Jichi Medical University

Publications: 45

Masato Kasuga

Masato Kasuga

National Center For Global Health and Medicine

Publications: 44

Stephen O'Rahilly

Stephen O'Rahilly

University of Cambridge

Publications: 43

Tohru Funahashi

Tohru Funahashi

Osaka University

Publications: 43

Something went wrong. Please try again later.